activins and Prostatic Neoplasms

activins has been researched along with Prostatic Neoplasms in 33 studies

Research

Studies (33)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (27.27)18.2507
2000's13 (39.39)29.6817
2010's10 (30.30)24.3611
2020's1 (3.03)2.80

Authors

AuthorsStudies
Chen, L; De Menna, M; Groenewoud, A; Kruithof-de Julio, M; Snaar-Jagalska, BE; Thalmann, GN1
Brown, J; Coleman, R; D'Oronzo, S; Handforth, C1
Chen, F; Fei, X; Jin, W; Song, Y; Wang, K; Wu, B1
Bergan, RC; Breen, MJ; Huang, X; Liu, W; Moran, DM; Vary, CP1
Bahn, A; Gold, E; Rodrigues, E; Sangkop, F; Singh, G1
Gold, EJ; Nicholson, HD; Ottley, EC1
Chang, C; Chuang, YC; Hsieh, CY; Huang, HY; Huang, KE; Kang, HY; Li, CF; Shyr, CR; Tsai, MY1
Atwood, CS; Bowen, RL; Bruce, E; Gallego, MJ; Haasl, RJ; Lyons, PF; Simon, DP; Vadakkadath Meethal, S; Weinecke, SL; Wilson, AC1
Badalamenti, G; Crescimanno, M; Flandina, C; Fulfaro, F; Incorvaia, L; Leto, G; Sepporta, MV; Tumminello, FM1
Gold, E; Risbridger, G1
Dautry, F; Havard, M; Tchénio, T1
Gold, E; Ottley, E1
de Jong, FH; Dits, NF; Hofland, J; Jenster, G; Steenbergen, J; van Weerden, WM1
Lin, SL1
Lin, SL; Ying, SY1
Bailey, PM; Carey, JL; Christian, B; Gupta, V; Kawakubo, H; Maheswaran, S; Sasur, LM1
Fujii, Y; Kageyama, Y; Kawakami, S; Kihara, K; Okada, Y1
Deix, T; Kirley, SD; Marberger, M; McDougal, WS; Oltean, H; Planz, B; Wang, QF1
Chen, G; Goto, K; Lu, J; Matsubara, E; Morinaga, H; Nawata, H; Nomura, M; Okabe, T; Yanase, T; Zheng, H1
Bakin, AV; Cowell, JK; Ionov, Y; Rossi, MR1
Badalamenti, G; Crescimanno, M; Flandina, C; Gebbia, N; Incorvaia, L; Leto, G; Rini, G; Tumminello, FM1
Bradshaw, D; Dalkin, AC; Gilrain, JT; Myers, CE1
Crowley, WF; Preffer, F; Schneyer, AL; Sluss, PM; Tilly, JL; Tilly, KI; Wang, QF1
Batres, Y; Lin, MF; Ying, SY; Zhang, Z; Zhao, Y1
Evans, LW; Groome, NP; Niclasen, P; O'Bryan, MK; Pedersen, J; Risbridger, GP; Thomas, TZ; Wang, H1
Gurusinghe, CJ; McPherson, SJ; Risbridger, GP; Thomas, TZ; Wang, H1
Risbridger, GP1
Garcia, FU; Liu, A; Rhim, JS; Stearns, ME; Wang, M1
Evans, LW; Groome, NP; McPherson, SJ; Mellor, SL; Risbridger, GP; Wang, H1
Chuong, CM; Lin, S; Ying, SY1
Cancilla, B; Risbridger, GP1
Dowling, CR; Risbridger, GP1
McPherson, SJ; Mellor, SL; Risbridger, GP; Schmitt, JF1

Reviews

6 review(s) available for activins and Prostatic Neoplasms

ArticleYear
Cancer Treatment and Bone Health.
    Calcified tissue international, 2018, Volume: 102, Issue:2

    Topics: Activins; Androgens; Antineoplastic Agents; Bone and Bones; Breast Neoplasms; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Inhibins; Male; Osteoporosis; Practice Guidelines as Topic; Prostatic Neoplasms

2018
Activins and activin antagonists in the prostate and prostate cancer.
    Molecular and cellular endocrinology, 2012, Aug-15, Volume: 359, Issue:1-2

    Topics: Activins; Animals; Cell Transformation, Neoplastic; Follistatin; Follistatin-Related Proteins; GPI-Linked Proteins; Humans; Inhibins; Intercellular Signaling Peptides and Proteins; Male; Membrane Proteins; Neoplasm Proteins; Prostate; Prostatic Neoplasms

2012
Insensitivity to the growth inhibitory effects of activin A: an acquired capability in prostate cancer progression.
    Cytokine & growth factor reviews, 2012, Volume: 23, Issue:3

    Topics: Activins; Cell Proliferation; Cell Transformation, Neoplastic; Disease Progression; Growth Inhibitors; Humans; Male; MicroRNAs; Prostatic Neoplasms

2012
Role of activins in the male reproductive tract.
    Reviews of reproduction, 2000, Volume: 5, Issue:2

    Topics: Activins; Animals; Cell Communication; Cell Division; Epididymis; Follistatin; Gene Expression Regulation; Glycoproteins; Humans; Inhibins; Male; Mice; Prostate; Prostatic Neoplasms; Rats; Testis

2000
The role of inhibins and activins in prostate cancer pathogenesis.
    Endocrine-related cancer, 2000, Volume: 7, Issue:4

    Topics: Activins; Animals; Humans; Inhibins; Male; Prostate; Prostatic Neoplasms; Signal Transduction; Testis

2000
The contribution of inhibins and activins to malignant prostate disease.
    Molecular and cellular endocrinology, 2001, Jun-30, Volume: 180, Issue:1-2

    Topics: Activins; Animals; Cell Division; Female; Humans; Inhibins; Male; Prostatic Neoplasms; Protein Subunits

2001

Other Studies

27 other study(ies) available for activins and Prostatic Neoplasms

ArticleYear
A NF-ĸB-Activin A signaling axis enhances prostate cancer metastasis.
    Oncogene, 2020, Volume: 39, Issue:8

    Topics: Activins; Animals; Cell Proliferation; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Male; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Neoplastic Stem Cells; NF-kappa B; PC-3 Cells; Prostatic Neoplasms; Signal Transduction; Smad Proteins; Up-Regulation; Zebrafish

2020
miR-15a/miR-16 cluster inhibits invasion of prostate cancer cells by suppressing TGF-β signaling pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 104

    Topics: Activins; Animals; Cadherins; Cell Line; Cell Line, Tumor; Down-Regulation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Male; Matrix Metalloproteinase 2; Mice; MicroRNAs; Neoplasm Invasiveness; NIH 3T3 Cells; Prostatic Neoplasms; Signal Transduction; Smad3 Protein; Snail Family Transcription Factors; Transforming Growth Factor beta; Twist-Related Protein 1

2018
Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors.
    PloS one, 2013, Volume: 8, Issue:8

    Topics: Activin Receptors, Type II; Activins; Antigens, CD; Bone Morphogenetic Protein Receptors, Type II; Cell Line, Tumor; Endoglin; Enzyme Activation; Humans; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Protein Binding; Protein Interaction Domains and Motifs; Receptors, Cell Surface; Signal Transduction; Smad1 Protein

2013
Uric acid: a modulator of prostate cells and activin sensitivity.
    Molecular and cellular biochemistry, 2016, Volume: 414, Issue:1-2

    Topics: Activins; Cell Line, Tumor; Glucose Transport Proteins, Facilitative; Humans; Male; Probenecid; Prostate; Prostatic Neoplasms; RNA, Messenger; Tissue Array Analysis; Transforming Growth Factor beta; Uric Acid

2016
Activin A regulates microRNAs and gene expression in LNCaP cells.
    The Prostate, 2016, Volume: 76, Issue:11

    Topics: Activins; Cell Cycle; Cell Line, Tumor; Gene Expression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Male; MicroRNAs; Polymerase Chain Reaction; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Transforming Growth Factor beta

2016
Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancer.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2009, Volume: 24, Issue:7

    Topics: Active Transport, Cell Nucleus; Activins; Apoptosis; Bone Neoplasms; Cell Movement; Cell Nucleus; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplasm Metastasis; Neoplasm Proteins; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Smad3 Protein; Transcription, Genetic; Tumor Cells, Cultured

2009
Activin receptor signaling regulates prostatic epithelial cell adhesion and viability.
    Neoplasia (New York, N.Y.), 2009, Volume: 11, Issue:4

    Topics: Activin Receptors, Type II; Activins; ADAM Proteins; Cell Adhesion; Cell Line, Tumor; Cell Survival; Epithelial Cells; Humans; Immunoblotting; Male; Membrane Proteins; Neuroblastoma; Prostatic Neoplasms; Signal Transduction

2009
Serum follistatin in patients with prostate cancer metastatic to the bone.
    Clinical & experimental metastasis, 2010, Volume: 27, Issue:8

    Topics: Activins; Aged; Bone Neoplasms; Follistatin; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Sensitivity and Specificity

2010
A dormant state modulated by osmotic pressure controls clonogenicity of prostate cancer cells.
    The Journal of biological chemistry, 2011, Dec-23, Volume: 286, Issue:51

    Topics: Activins; Animals; Cell Cycle; Cell Line, Tumor; Culture Media, Conditioned; Humans; Male; Mice; Neoplasm Metastasis; Neoplasms; NIH 3T3 Cells; Osmosis; Prostatic Neoplasms; Signal Transduction; Tumor Suppressor Protein p53

2011
Activin A stimulates AKR1C3 expression and growth in human prostate cancer.
    Endocrinology, 2012, Volume: 153, Issue:12

    Topics: 3-Hydroxysteroid Dehydrogenases; Activins; Aldo-Keto Reductase Family 1 Member C3; Androgens; Animals; Cell Line, Tumor; Cell Proliferation; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Hydroxyprostaglandin Dehydrogenases; Male; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Prostatic Neoplasms; Signal Transduction; Testosterone

2012
Single-cell mRNA library analysis by Northern blot hybridization.
    Methods in molecular biology (Clifton, N.J.), 2003, Volume: 221

    Topics: Activins; Biomarkers, Tumor; Blotting, Northern; Gene Expression; Gene Library; Humans; Male; Nucleic Acid Hybridization; Polymerase Chain Reaction; Prostatic Neoplasms; RNA, Messenger; Tumor Cells, Cultured

2003
Gene expression in precursor cells of prostate cancer associated with activin by combination of subtractive hybridization and microarray technologies.
    Biochemical and biophysical research communications, 2004, Jan-02, Volume: 313, Issue:1

    Topics: Activins; Blotting, Northern; Cell Line, Tumor; Disease Progression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplasm Staging; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; RNA, Neoplasm

2004
Mutually antagonistic effects of androgen and activin in the regulation of prostate cancer cell growth.
    Molecular endocrinology (Baltimore, Md.), 2004, Volume: 18, Issue:3

    Topics: Activins; Androgens; Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p27; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; Humans; Inhibin-beta Subunits; Male; Phosphorylation; Prostate-Specific Antigen; Prostatic Neoplasms; Retinoblastoma Protein; S Phase; Smad3 Protein; Trans-Activators; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins

2004
Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells.
    American journal of physiology. Endocrinology and metabolism, 2004, Volume: 286, Issue:6

    Topics: Activins; Androgens; Cell Division; Cell Line, Tumor; Dihydrotestosterone; Drug Interactions; Gene Expression; Humans; Inhibin-beta Subunits; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Up-Regulation

2004
Effect of keratinocyte growth factor and activin on cell growth in the human prostatic cancer cell line LNCaP.
    World journal of urology, 2004, Volume: 22, Issue:2

    Topics: Activins; Cell Division; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Humans; Male; Prostatic Neoplasms; Tumor Cells, Cultured

2004
Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor.
    The Journal of biological chemistry, 2005, Oct-28, Volume: 280, Issue:43

    Topics: Activins; Animals; Blotting, Western; Cell Line, Tumor; Cell Nucleus; Chlorocebus aethiops; COS Cells; Dihydrotestosterone; Dose-Response Relationship, Drug; Forkhead Transcription Factors; Green Fluorescent Proteins; Humans; Image Processing, Computer-Assisted; Immunoprecipitation; Inhibin-beta Subunits; Ligands; Male; Microscopy, Confocal; Plasmids; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Binding; Receptors, Androgen; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA; Smad2 Protein; Smad4 Protein; Transcriptional Activation; Transfection; Two-Hybrid System Techniques

2005
Truncating mutations in the ACVR2 gene attenuates activin signaling in prostate cancer cells.
    Cancer genetics and cytogenetics, 2005, Volume: 163, Issue:2

    Topics: Activin Receptors; Activins; Base Sequence; Cell Line, Tumor; DNA Primers; Gene Expression; Humans; Male; Mutation; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction

2005
Activin A circulating levels in patients with bone metastasis from breast or prostate cancer.
    Clinical & experimental metastasis, 2006, Volume: 23, Issue:2

    Topics: Activins; Aged; Aged, 80 and over; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Humans; Male; Middle Aged; Osteoporosis; Prostatic Hyperplasia; Prostatic Neoplasms; Sensitivity and Specificity

2006
Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells.
    Endocrinology, 1996, Volume: 137, Issue:12

    Topics: Activin Receptors; Activins; Androgens; Cell Division; Drug Resistance; Follistatin; Glycoproteins; Humans; Inhibins; Male; Promoter Regions, Genetic; Prostatic Neoplasms; Receptors, Growth Factor; RNA, Messenger; Transforming Growth Factor beta; Tumor Cells, Cultured

1996
Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP.
    Endocrinology, 1996, Volume: 137, Issue:12

    Topics: Activin Receptors; Activins; Androgens; Apoptosis; Cell Division; Cell Separation; DNA Fragmentation; Flow Cytometry; Humans; Inhibins; Male; Prostatic Neoplasms; Receptors, Growth Factor; Tumor Cells, Cultured

1996
Regulation of growth and prostatic marker expression by activin A in an androgen-sensitive prostate cancer cell line LNCAP.
    Biochemical and biophysical research communications, 1997, May-19, Volume: 234, Issue:2

    Topics: Acid Phosphatase; Activins; Androgens; Biomarkers, Tumor; Cell Differentiation; Cell Division; Humans; Inhibins; Male; Neoplasms, Hormone-Dependent; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Recombinant Proteins

1997
Expression and localization of activin subunits and follistatins in tissues from men with high grade prostate cancer.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:11

    Topics: Activins; Animals; Biopsy, Needle; Epithelium; Follistatin; Gene Expression; Glycoproteins; Humans; Inhibins; Male; Prostatic Neoplasms; Rabbits; RNA, Messenger; Stromal Cells; Tumor Cells, Cultured

1997
Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145.
    The Journal of endocrinology, 1997, Volume: 154, Issue:3

    Topics: Activins; Adjuvants, Immunologic; Blotting, Southern; DNA; Dose-Response Relationship, Drug; Follistatin; Glycoproteins; Growth Substances; Humans; Immunohistochemistry; Inhibins; Male; Oligopeptides; Peptides; Polymerase Chain Reaction; Prostatic Neoplasms; Tumor Cells, Cultured

1997
Recent progress in our understanding of inhibin in the prostate gland.
    The Journal of endocrinology, 1998, Volume: 157, Issue:1

    Topics: Activins; Animals; Follicle Stimulating Hormone; Follistatin; Glycoproteins; Growth Substances; Humans; Inhibins; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Tumor Cells, Cultured

1998
Growth of HPV-18 immortalized human prostatic intraepithelial neoplasia cell lines. Influence of IL-10, follistatin, activin-A, and DHT.
    International journal of oncology, 1999, Volume: 14, Issue:6

    Topics: Activins; Adjuvants, Immunologic; Androgens; Animals; Blotting, Western; Cell Adhesion; Cell Division; Cell Line, Transformed; Cell Transformation, Viral; Colony-Forming Units Assay; Dehydroepiandrosterone; Dihydrotestosterone; Enzyme-Linked Immunosorbent Assay; Follistatin; Glycoproteins; Growth Substances; Humans; Inhibins; Interleukin-10; Light; Male; Mice; Mice, SCID; Microscopy; Papillomaviridae; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Tumor Cells, Cultured

1999
Expression of activin A and follistatin core proteins by human prostate tumor cell lines.
    Endocrinology, 1999, Volume: 140, Issue:11

    Topics: Activins; Alternative Splicing; Blotting, Western; Culture Media, Conditioned; Enzyme-Linked Immunosorbent Assay; Follistatin; Gene Expression; Glycoproteins; Humans; Immunohistochemistry; Inhibins; Male; Prostatic Neoplasms; RNA, Messenger; Tumor Cells, Cultured

1999
Suppression of activin-induced apoptosis by novel antisense strategy in human prostate cancer cells.
    Biochemical and biophysical research communications, 1999, Nov-30, Volume: 265, Issue:3

    Topics: Activins; Antisense Elements (Genetics); Apoptosis; Gene Expression; Gene Targeting; Humans; Inhibins; Male; Phenotype; Prostatic Neoplasms; Protein Kinases; RNA, Messenger; Transfection; Tumor Cells, Cultured

1999